| P50 | author | Massimo Andreoni | Q39747196 |
| | Nicola Coppola | Q41549306 |
| | Evangelista Sagnelli | Q41549310 |
| | Raffaele Bruno | Q44368784 |
| | Gioacchino Angarano | Q56424445 |
| P2093 | author name string | M Galli | |
| | G B Gaeta | |
| | G Rizzardini | |
| | G Carosi | |
| | O Armignacco | |
| | G Di Perri | |
| | T Santantonio | |
| | M Puoti | |
| | G D'Offizi | |
| | G Taliani | |
| | Italian Society for the Study of Infectious and Tropical Diseases | |
| P2860 | cites work | Effect of Ursodeoxycholic Acid in Acute Viral Hepatitis | Q61770477 |
| | Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: a pilot study | Q78196038 |
| | Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses | Q78787040 |
| | A randomized controlled trial of lamivudine to treat acute hepatitis B | Q79449890 |
| | Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure | Q83367686 |
| | Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure | Q27499349 |
| | EASL clinical practice guidelines: Management of chronic hepatitis B virus infection | Q29615868 |
| | Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial | Q34181574 |
| | Viral determinants and host immune responses in the pathogenesis of HBV infection. | Q34737124 |
| | Review article: albumin as a drug--biological effects of albumin unrelated to oncotic pressure | Q34992524 |
| | N-acetyl cysteine therapy in acute viral hepatitis | Q36180480 |
| | EASL Clinical Practice Guidelines: management of chronic hepatitis B. | Q37340737 |
| | Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat? | Q37958234 |
| | Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults | Q39375841 |
| | Anti-hepatitis B virus activity of N-acetyl-L-cysteine (NAC): new aspects of a well-established drug | Q41178536 |
| | Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B. | Q42257697 |
| | The study of efficacy of lamivudine in patients with severe acute hepatitis B. | Q43231277 |
| | Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary results | Q44578777 |
| | Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States | Q44949690 |
| | Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience | Q47212247 |
| P433 | issue | 5 | |
| P921 | main subject | position paper | Q7233193 |
| P304 | page(s) | 811-815 | |
| P577 | publication date | 2014-07-06 | |
| P1433 | published in | Infection | Q15710156 |
| P1476 | title | Recommendations for the management of acute hepatitis B: position paper of the Italian Society for the Study of Infectious and Tropical Diseases (SIMIT) | |
| P478 | volume | 42 | |